Zhao Y, Wu J, Liu X, Chen X, Wang J
Front Pharmacol. 2025; 15:1467193.
PMID: 39877388
PMC: 11772364.
DOI: 10.3389/fphar.2024.1467193.
Xuan S, Ma Y, Zhou H, Gu S, Yao X, Zeng X
Genes Dis. 2024; 11(6):101007.
PMID: 39238498
PMC: 11375267.
DOI: 10.1016/j.gendis.2023.04.036.
Chaudhary A, Mehra P, Keshri A, Rawat S, Mishra A, Prasad A
Mol Neurobiol. 2023; 61(3):1527-1542.
PMID: 37725212
DOI: 10.1007/s12035-023-03639-7.
Adori M, Khoenkhoen S, Zhang J, Dopico X, Karlsson Hedestam G
Cells. 2023; 12(9).
PMID: 37174629
PMC: 10177494.
DOI: 10.3390/cells12091229.
Mahish C, De S, Chatterjee S, Ghosh S, Keshry S, Mukherjee T
Front Immunol. 2023; 14:1139808.
PMID: 37153546
PMC: 10157217.
DOI: 10.3389/fimmu.2023.1139808.
Haemophilus ducreyi Infection Induces Oxidative Stress, Central Metabolic Changes, and a Mixed Pro- and Anti-inflammatory Environment in the Human Host.
Brothwell J, Fortney K, Gao H, Wilson L, Andrews C, Tran T
mBio. 2022; 13(6):e0312522.
PMID: 36453940
PMC: 9765465.
DOI: 10.1128/mbio.03125-22.
Therapeutic Potentials of Secoiridoids from the Fruits of Aiton against Inflammation-Related Skin Diseases.
Yeon S, Choi S, Liu Q, Jo Y, Choi D, Kim M
Pharmaceuticals (Basel). 2022; 15(8).
PMID: 36015080
PMC: 9415915.
DOI: 10.3390/ph15080932.
Ghosts as a Vehicle for the Delivery of DNA Vaccines Mediate Immune Responses.
Yu X, Wang L, Yang X, Zhang S, Li G, Zhang L
Front Immunol. 2022; 13:849409.
PMID: 35711427
PMC: 9193971.
DOI: 10.3389/fimmu.2022.849409.
TLR4/MD-2 is a receptor for extracellular nucleophosmin 1.
Nakatomi K, Ueno H, Ishikawa Y, Salim R, Mori Y, Kanemoto I
Biomed Rep. 2020; 14(2):21.
PMID: 33335727
PMC: 7739869.
DOI: 10.3892/br.2020.1397.
Toll-like Receptors and the Control of Immunity.
Fitzgerald K, Kagan J
Cell. 2020; 180(6):1044-1066.
PMID: 32164908
PMC: 9358771.
DOI: 10.1016/j.cell.2020.02.041.
Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators.
Nigar S, Shimosato T
Front Nutr. 2019; 6:140.
PMID: 31508424
PMC: 6718720.
DOI: 10.3389/fnut.2019.00140.
Ca2+/Calmodulin-dependent kinase II delta B is essential for cardiomyocyte hypertrophy and complement gene expression after LPS and HSP60 stimulation in vitro.
Cruz Junho C, Trentin-Sonoda M, Alvim J, Gaisler-Silva F, Carneiro-Ramos M
Braz J Med Biol Res. 2019; 52(7):e8732.
PMID: 31314855
PMC: 6644523.
DOI: 10.1590/1414-431X20198732.
The Role of RP105 in Cardiovascular Disease through Regulating TLR4 and PI3K Signaling Pathways.
Yang J, Zeng P, Yang J, Fan Z
Curr Med Sci. 2019; 39(2):185-189.
PMID: 31016532
DOI: 10.1007/s11596-019-2017-3.
Chlamydia trachomatis Lipopolysaccharide Evades the Canonical and Noncanonical Inflammatory Pathways To Subvert Innate Immunity.
Yang C, Briones M, Chiou J, Lei L, Patton M, Ma L
mBio. 2019; 10(2).
PMID: 31015326
PMC: 6479002.
DOI: 10.1128/mBio.00595-19.
CEACAM1 regulates the IL-6 mediated fever response to LPS through the RP105 receptor in murine monocytes.
Zhang Z, La Placa D, Nguyen T, Kujawski M, Le K, Li L
BMC Immunol. 2019; 20(1):7.
PMID: 30674283
PMC: 6345024.
DOI: 10.1186/s12865-019-0287-y.
Mechanisms of Intravascular Linear Ablation Induced Restenosis in Rabbit Abdominal Aorta.
Chen Q, Wang M, Shao S, Liu H, Xia X, Tse G
Biomed Res Int. 2019; 2018:7459276.
PMID: 30671470
PMC: 6323460.
DOI: 10.1155/2018/7459276.
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection.
Fukui R, Murakami Y, Miyake K
Inflamm Regen. 2018; 38:11.
PMID: 29988708
PMC: 6029368.
DOI: 10.1186/s41232-018-0068-7.
RP105 alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways.
Yang J, Yang C, Yang J, Ding J, Li X, Yu Q
Int J Mol Med. 2018; 41(6):3287-3295.
PMID: 29512709
PMC: 5881694.
DOI: 10.3892/ijmm.2018.3538.
Chanzyme TRPM7 Mediates the Ca Influx Essential for Lipopolysaccharide-Induced Toll-Like Receptor 4 Endocytosis and Macrophage Activation.
Schappe M, Szteyn K, Stremska M, Mendu S, Downs T, Seegren P
Immunity. 2018; 48(1):59-74.e5.
PMID: 29343440
PMC: 5783319.
DOI: 10.1016/j.immuni.2017.11.026.
Nuciferine Ameliorates Inflammatory Responses by Inhibiting the TLR4-Mediated Pathway in Lipopolysaccharide-Induced Acute Lung Injury.
Wu H, Yang Y, Guo S, Yang J, Jiang K, Zhao G
Front Pharmacol. 2018; 8:939.
PMID: 29311940
PMC: 5742629.
DOI: 10.3389/fphar.2017.00939.